Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
Clinical trial NCT00103506 · COMPLETED
Trial details
- NCT number
- NCT00103506
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2014-05-01
- Enrollment
- 646
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.